Strides Pharma Science Ltd - 532531 - Intimation Under Regulation 31A Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations).
Request received from SeQuent Scientific Limited for reclassification of shareholding from 'Promoter Group' to 'Public' Category' Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sequent Scientific Ltd Strides Pharma hits a fresh 52-week high; stock gains 14% in one week
The company had reported a strong improvement in profitability in Q1 despite Ranitidine suspension in Q4. Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pronomz Ventures LLP Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pronomz Ventures LLP Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 25, 2020 for Pronomz Ventures LLP & Arun Kumar Pillai Six months since lockdown: Strides in testing, vaccine devt but COVID crisis far from over in India, say scientists
Six months on, India has the second highest number of cases in the world after the US with a tally of 57.32 lakh cases, 86,508 people testing positive in a day and a total of 91,149 fatalities, according to Union Health Ministry figures on Thursday.
Strides Pharma Science shares up 3% as subsidiary gets USFDA nod
Singapore-based Strides Pharma Global Pte Ltd has received approval from the US health regulator for Butalbital, Acetaminophen, and Caffeine tablets, used to treat tension headaches. Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides receives USFDA approval for Butalbital, Acetaminophen, and Caffeine Tablets Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pronomz Ventures LLP